. CC is a progressive dysfunctional illness, in which transforming growth factor beta (TGF-β) plays a central role in fibrogenesis and hypertrophy. In the present study, we tested in a three-dimensional (3D) model of cardiac cells culture (named cardiac spheroids), capable of mimicking the aspects of fibrosis and hypertrophy observed in CC, the role of TGF-β pathway inhibition in restoring extracellular matrix (ECM) balance disrupted by T. cruzi infection. Treatment of T. cruzi-infected cardiac spheroids with SB 431542, a selective inhibitor of TGF-β type I receptor, resulted in a reduction in the size of spheroids, which was accompanied by a decrease in parasite load and in fibronectin expression. The inhibition of TGF-β pathway also promoted an increase in the activity of matrix metalloproteinase (MMP)-2 and a decrease in tissue inhibitor of matrix metalloproteinase (TIMP)-1 expression, which may be one of the mechanisms regulating extracellular matrix remodeling. Therefore, our study provides new insights into the molecular mechanisms by which inhibition of TGF-β signaling reverts fibrosis and hypertrophy generated by T. cruzi during CC and also highlights the use of cardiac spheroids as a valuable tool for the study of fibrogenesis and anti-fibrotic compounds.
Introduction
Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, is endemic in Latin America and affects about seven million people worldwide [1] . About 30% of infected individuals develop clinical manifestations of chronic CD, in which the cardiac form is the most frequent and severe [2] . Parasite persistence and chronic inflammation result in myocardial remodeling with the contribution of fibrosis and hypertrophy to functional abnormalities and heart failure during chagasic cardiomyopathy (CC) [3] . There is no effective treatment available for the chronic phase and patients with CC have shortened life expectancy [2] . Transforming growth factor-β (TGF-β) pathway is implicated in several regulatory aspects of CC pathogenesis and can be considered as an emerging target for treatment of CD [4] .
In fibrosis, TGF-β contributes to the activation of fibroblasts, stimulation of epithelial-mesenchymal transition (EMT), production of extracellular matrix (ECM) fibers and modulation of matrix metalloproteases (MMPs) and tissue inhibitor of MMPs (TIMPs) [5, 6] . Patients with CD present higher levels of (1) circulating TGF-β, (2) phosphorylated SMAD2 (pSMAD2) and (3) fibronectin (FN) in the cardiac tissue [7] . Also, studies showed that pharmacological inhibition of TGF-β signaling effectively decreased infection and reversed the extent of myocardial fibrosis in models of acute Chagas disease [8, 9] . However, the mechanisms underlying these processes remain unknown.
We previously developed a three-dimensional (3D) model of cardiac cells culture, named cardiac spheroids, that when infected by T. cruzi, reproduces aspects of CC, including fibrosis and hypertrophy [10] , similar to that observed in vivo in murine models and patients with CC [7, 11, 12] . 3D cultures have been intensely applied in studies involving drug screening and cytotoxicity assays [13, 14] . Also, pharmacological strategies to treat fibrosis have been tested in 3D culture models [15, 16] , including the use of compounds that can reduce the expression of TGF-β [16] .
Here, we tested in a 3D model of multicellular cardiac spheroids the efficacy of the pharmacological inhibitor of TGF-β signaling, SB 431542, in restoring ECM balance disrupted by T. cruzi infection and some of the possible mechanisms involved in this process.
Results

Analysis of TGF-β secretion and TGF-β/SMAD signaling pathway
Considering that cardiac spheroids may reproduce the myocardium microenvironment, we first analyzed whether T. cruzi infection upregulates the levels of TGF-β in the supernatant of 3D cultures, as previously described in CC [7] . T. cruzi infection induced a progressive increase in TGF-β secretion (Fig. 1A ), peaking at 72 h post-infection (hpi) and declining to basal levels after 240 hpi, where TGF-β levels become similar to control. We, then, analyzed the effect of SB 431542 on TGF-β secretion. We observed that T. cruzi-infected cardiac spheroids treated with SB 431542 exhibited a small but consistent reduction of 7% in the secreted levels of TGF-β when compared to untreated and infected cardiac spheroids at the latest stage of infection (Fig. 1B) .
Additionally, we assessed the efficacy of SB 431542 on inhibiting TGF-β signaling by analyzing the expression of pSMAD2 (Fig. 1C) , a key intracellular signal transducer of the canonical TGF-β pathway. Treatment of infected cardiac spheroids with SB 431542 resulted in a significant 54% reduction of pSMAD2 expression (Fig. 1D ), indicating that treatment could impair the activation of TGF-β/SMAD pathway that had been previously triggered by T. cruzi infection.
Volume analysis of cardiac spheroids
As TGF-β is a molecule known to be involved in the modulation of different signals leading to heart remodeling in CC [21] , we decide to investigate the effect of TGF-β signaling inhibition over the global size of cardiac spheroids. As previously observed [10] , T. cruzi-infection led to a significant increase of 67% in the volume of cardiac spheroids, while treatment of T. cruzi-infected cardiac spheroids with SB 431542 led to a 19% reduction in the volume of cardiac spheroids (Fig. 2) . These data show that in our 3D model TGF-β pathway also participates in the remodeling of cardiac structures triggered by T. cruzi infection.
Quantification of parasite load
The observation that SB 431542 could reduce the volume of cardiac spheroids led us questioning whether this was due to a decrease in parasitism, a reduction in the secretion of ECM molecules or even a and non-infected (NI, n = 6) cardiac spheroids. Boxes extend from the 25th to 75th percentiles, the lines in the middle represent median values while horizontal lines correspond to 95% confidence intervals. **P < 0.01. Data were analyzed in SPSS using Mann-Whitney (asterisks) and Median test (p-value outside the box).
combination of these events. To answer this question, we first quantified by quantitative real-time PCR (qPCR) the amount of T. cruzi in infected cardiac spheroids, treated or not with SB 431542, at the latest time of our study. We observed that inhibition of TGF-β pathway led to a 26% reduction in parasite load (Fig. 3) , suggesting that decrease in parasitism may be one of the reasons for volume reduction of treated cardiac spheroids.
Analysis of ECM proteins
We further evaluated the effect of SB 431542 on the expression levels and distribution patterns of FN (Fig. 4) and laminin (LN) (Fig. 5) , two fibrogenesis markers of T. cruzi infection [7, 22] . Western blot data showed that T. cruzi infection induced an expressive 4-fold increase in FN expression. Treatment of T. cruzi-infected cardiac spheroids with SB 431542 effectively reduced the levels of FN in about 33% ( Fig. 4A and  B) .
The analysis of LN revealed that infection of cardiac spheroids also led to a significant increase of 77% in the expression pattern of this protein. Inhibition of TGF-β pathway did not significantly reduce the expression of LN in T. cruzi-infected cardiac spheroids ( Fig. 5A and B) .
Confocal images of cardiac spheroids immunostained for FN and LN revealed that, after 240 h of infection, the 3D structure of spheroids present a dense ECM network with the presence of a high number of parasites distributed along it ( Fig. 4C and Fig. 5C ). FN was observed within the cell sheets, separating the internal cardiac cell clumps as a fibrillar network (Fig. 4E) . T. cruzi infection resulted in a matrix remodeling, showing an enhancement of FN deposit (Fig. 4C ). FN staining of cardiac spheroids treated with SB 431542 confirmed the reduction of this protein (Fig. 4D ), as previously observed by western blot. Immunofluorescence analysis of LN showed that T. cruzi infection also changed the distribution pattern of LN in cardiac spheroids and resulted in its accumulation in the 3D structures ( Fig. 5C and E). Treatment of infected cardiac spheroids with SB 431542 did not change the staining pattern of LN generated by T. cruzi infection (Fig. 5D ).
Analysis of matrix metalloproteinase (MMP)-2 and MMP-9 activities
As we observed that SB 431542 could partially restore ECM balance, we decided to investigate the participation of MMP-2 and MMP-9 in this process. Analysis of zymography gels ( Fig. 6A ) indicated that infection reduced MMP-2 and MMP-9 activities in 37% and 15%, respectively. Treatment of T. cruzi-infected cardiac spheroids with SB 431542 enhanced the activity of MMP-2 significantly in about 8%, while the activity of MMP-9 remained unaltered ( Fig. 6B and C) . Fig. 3 . Treatment of infected cardiac spheroids reduced parasite load. Total DNA from T. cruzi-infected cardiac spheroids treated (IT) or not (I) with SB 431542 were analyzed by quantitative real-time PCR using primers targeting nuclear satellite DNA from T. cruzi and mice's GAPDH. Results were expressed as the ratio of T. cruzi/host cell equivalents. The ratio value obtained for T. cruzi-infected cardiac spheroids was taken as 100%. Box plots represent the median values of quantified parasite load. Boxes extend from the 25th to 75th percentiles, the lines in the middle represent median values while horizontal lines correspond to 95% confidence intervals. *P < 0.05, n = 3. Data were analyzed in SPSS using Mann-Whitney test (asterisk). Boxes extend from the 25th to 75th percentiles, the lines in the middle represent median values while horizontal lines correspond to 95% confidence intervals. Data were analyzed in SPSS using Mann-Whitney (asterisks) and Median test (p-value outside the box). **P < 0.01, n = 5. (C-E) Representative confocal images of FN distribution (green) in infected (I, C), infected and treated (IT, D) and non-infected cardiac spheroids (NI, E). Parasites (arrows) and cardiac cell nuclei (asterisks) are seen in blue by DAPI staining and can be better observed in the inset (C). An infected and non-treated cardiac spheroid can be observed presenting abundant staining for FN (C) that is reduced by treatment with SB 431542 (D).
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Analysis of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) expression
To better understand the mechanisms regulating MMP-2 and MMP-9 activities, we decided to check if one of the intrinsic regulators of MMPs, TIMP-1, had its expression altered by both T. cruzi infection and treatment with SB 431542 (Fig. 6D) . In our assays, we could not detect bands of TIMP-1 in non-infected spheroids, indicating a probable low abundance of this protein in these biological samples. On the other hand, T. cruzi infection triggered a higher production of TIMP-1, while treatment of infected cardiac spheroids with SB 431542 resulted in a 34% decrease in TIMP-1 expression (Fig. 6E ).
Discussion
In this study, we adopted a 3D model of cardiac spheroids, which has previously shown to reproduce some aspects of CC, such as fibrosis and hypertrophy [10] . We focused on understanding if the pharmacological inhibitor of TGF-β signaling, SB 431542, could revert cardiac fibrosis triggered by T. cruzi infection and some of the mechanisms involved in this process. We initiated our study by assessing the levels of TGF-β secreted by cardiac spheroids over the course of infection. Although infection induced a progressive increase in TGF-β secretion at least until the first 72 h, levels of TGF-β in infected spheroids gradually declined, becoming in our last time analyzed, similar to that observed in non-infected spheroids. ECM components may have an important influence on TGF-β secretion since this growth factor remains connected to the ECM after its production in a latent form. As we observed a higher FN and LN deposition in infected spheroids, these matrix components may be contributing to a greater retention of TGF-β and thus leading to a smaller secretion of this molecule in culture supernatants. However, we cannot discard the possibility that increased levels of TGF-β observed in earlier points may have triggered downregulation of TGF-β by cardiac cells, since high levels may be harmful to the cardiac environment.
When we evaluated how treatment affects TGF-β signaling, we observed that the lower levels of secreted TGF-β observed in T. cruzi infected and treated spheroids were accompanied by a reduction in the activation of TGF-β pathway. As the analysis of pSMAD2 expression occurred at the end of treatment, our data indicate that probably the inhibitory effect of SB 431542 on the canonical TGF-β signaling pathway persisted for a longer period. Treatment with SB 431542 also promoted a significant reduction in the volume of spheroids, showing that inhibition of TGF-β pathway leads to inhibition of the stimuli responsible for size increase of the infected cardiac spheroids. In T. cruzi infected and treated cardiac spheroids, volume reduction can be at least partially attributed to changes in parasitism, since treatment with SB 431542 reduced the parasite load. This result is consistent with previous studies that showed that TGF-β pathway is directly associated with T. cruzi invasiveness capacity [23] [24] [25] and with the progression of parasite's intracellular cycle [26, 27] . Also, it was previously shown that treatment with SB 431542 reduced the parasitemia and cardiac parasitism in mice during acute CD [9] , reinforcing the reliability of our data and the robustness of our 3D system. Reduction in volume can also be attributed to a decrease in ECM components. Here we showed that treatment with SB 431542 reduced the expression of FN significantly, but not the expression of LN, although a trend of decrease could be observed. During CD, FN is highly expressed in cardiac tissue, both in animal models [11, 12] and humans [7, 9] . Our results show for the first time that the in vitro treatment with SB 431542 reduces fibrosis in the cardiac tissue environment, in accordance with previous data of cardiac fibrosis reduction in the heart of T. cruzi-infected mice after TGF-β pathway inhibition [8] .
Cardiac spheroids are mainly composed of cardiomyocytes but a population of connective tissue cells, including fibroblasts, is also present. As we previously demonstrated, FN appears to be produced by a small number of cells with a fibroblastoid morphology, generally located at the periphery of the spheroids [28] . It is known that tissue injuries provoked by T. cruzi lead to the replacement of functional tissue into the connective tissue [29] . This process, in other cardiac diseases, is triggered by conversion of fibroblasts into myofibroblasts, in which TGF-β plays a key role [5] . Therefore, we speculate that one of the Box plots represent the median values of normalized LN levels. Boxes extend from the 25th to 75th percentiles, the lines in the middle represent median values while horizontal lines correspond to 95% confidence intervals. Data were analyzed in SPSS using Mann-Whitney (asterisks) and Median test (p-value outside the box). ***P < 0.001. (C-E) Representative confocal images of LN distribution (green) in infected (I, C), infected and treated (IT, D) and non-infected cardiac spheroids (NI, E). Parasites and nuclei of cardiac cells can be observed in blue by DAPI staining. I and IT cardiac spheroids (C and D, respectively) can be seen presenting LN in the total area of spheroids, while in NI cardiac spheroids the staining is less abundant and more peripheral (E).
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probable effects of SB 431542 on the reduction of ECM components is related to the impairment of fibroblasts conversion by TGF-β signaling inhibition.
T. cruzi presents a complex relationship with ECM components. Many studies show that the parasite needs to attach and degrade ECM components through its proteases to reach and invade host cells [30, 31] . FN and LN are among the best well-described proteins related to T. cruzi invasion process [32] [33] [34] [35] since they are main components of the basement membrane. Considering this, we can speculate that reduction in the expression and deposition of ECM components promoted by SB 431542 can also be one of the reasons for the reduction in parasitism, along with the influence of TGF-β signaling on parasite's intracellular differentiation, as previously demonstrated [26, 27] .
To find some possible molecules involved in ECM degradation, we evaluated MMP-2 and MMP-9 activities, which have an affinity for many substrates, among them, basement membrane proteins, such as FN and LN [36] . In our study, infection of cardiac spheroids reduced the activity of both MMP-2 and MMP-9, which may be corroborating the observed increase in ECM deposition. These results indicate another mechanism by which infection can stimulate the development of fibrosis, along with upregulation of ECM proteins expression. Analysis of infected and treated cardiac spheroids indicates that treatment can partially restore MMP-2 activity and this may be one of the mechanisms by which SB 431542 acts against fibrosis triggered by T. cruzi infection.
MMP-2 and MMP-9 seem to play different roles in the pathogenesis of CD. Our group showed [37] that MMP-9 levels are predominant in the serum of patients with the cardiac (CARD) form of CD, while MMP-2 levels are predominant in the serum of patients with the indeterminate (IND) form. In this study, in which CD8+ T cells were found to be the main mononuclear leukocyte source of MMPs production, MMP-9 was associated with signals related to inflammation and fibrosis, while MMP-2 correlated with regulatory cytokines, indicating a possible protective role in cardiac remodeling. The capability of these sera to stimulate the production of ECM components in our 3D model of cardiac spheroids was also evaluated [37] . Sera-stimulated cardiac spheroids presented an increased expression of some ECM proteins, especially in IND group, including MMP-2 and FN. In a more recent study, neutrophils and monocytes, collected from the serum of patients with CARD and IND forms, were shown to express higher levels of MMP-9 and MMP-2 than the ones from non-infected individuals, and a similar correlation with inflammation and immune regulation was found for MMP-9 and MMP-2, respectively [38] . Although these findings suggest an important association between these proteolytic enzymes and the immune response in the development of CC, it is worth Boxes extend from the 25th to 75th percentiles, the lines in the middle represent median values while horizontal lines correspond to 95% confidence intervals. All data were analyzed in SPSS using Mann-Whitney (asterisks) and Median test (p-values outside the boxes). **P < 0.01, n = 5.
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Experimental Cell Research 362 (2018) [260] [261] [262] [263] [264] [265] [266] [267] to highlight that the balance between MMP-2 and MMP-9 in sera may not reflect the one found in the cardiac environment.
Since there is no influx of immune cells in our system, the results presented here reveal the effect of TGF-β pathway inhibition over the remodeling induced directly by the parasite. In this context, our findings reinforce the importance of parasite persistence on the pathogenesis of CC, not only as a stimulus to attract inflammatory cells but also as a direct contributor for cardiac fibrosis.
Considering that MMP-2 and MMP-9 seem to play a significant role in the development of CC, the understanding of how they are regulated becomes extremely valuable. The activity of MMPs can be endogenously regulated by TIMPs, which can form complexes with MMPs and irreversibly inactivate them by binding to their catalytic zinc cofactor [39] . Like MMPs, TIMPs can also be modulated by TGF-β [36, 40] and for that reason, we decide to investigate the behavior of TIMP-1, an intrinsic regulator of MMP-2 and MMP-9 activities. In our study, treatment of infected spheroids led to a decrease in the expression of TIMP-1. Thus, we speculate that the molecular signals triggered by T. cruzi infection, favorable for TIMP-1 production, are at least partially related to TGF-β signaling since treatment with SB 431542 was capable of reducing TIMP-1 levels.
Conclusions
In this study, we observed that treatment of T. cruzi-infected cardiac spheroids with a pharmacological inhibitor of TGF-β pathway, SB 431542, could partially restore ECM balance by reducing both parasite load and FN expression as well as by stimulating matrix degradation through down-regulation of TIMP-1 and increase of MMP-2 activity. Our study helps to unravel some of the mechanisms through which treatment with SB 431542 results in the reversion of fibrosis generated by T. cruzi infection. Together, these data show that cardiac spheroids can be used as a valuable tool to evaluate in vitro the molecular mechanisms regulating fibrosis and also the modulatory role of anti-fibrotic compounds.
Experimental procedures
3D cardiac cells culture
Cardiac cells obtained from heart embryos of 18-day-old Swiss Webster mice were subjected to enzymatic dissociation using 0.05% trypsin (Gibco, Life Technologies) and 0.01% collagenase (Worthington Biochemical Corporation) in PBS at 37°C, as previously described [17] . Animals were bred and manipulated according to the protocol approved by FIOCRUZ Ethical Committee in Animal Use (CEUA-FIOCRUZ license LW-40/13). Cells were plated in the 60 internal wells (25 × 10 3 cells/well) of agarose-coated 96-U-well plastic plates (Nunc). The 36 wells from extremities were filled with sterile water to maintain a humid atmosphere. Cultures were maintained at 37°C in a 5% CO 2 atmosphere in DMEM supplemented with 10% fetal bovine serum / 1 mmol/L CaCl 2 / 1 mmol/L L-glutamine / 2% chick embryo extract / 1000 U/mL penicillin / 50 μg/mL streptomycin.
Infection and treatment of cardiac spheroids
Trypomastigote forms of T. cruzi (Y strain) were obtained from the supernatant of previously infected primary cardiac cell cultures grown in DMEM supplemented as described above. After seven days of culture, cardiac spheroids were infected with T. cruzi in a proportion of 20:1 (parasite: host cell). Treatment occurred 144 h after infection, when the spheroids already present an elevated fibrogenesis, as previously described [10] . For each biological replicate, three plates were prepared: one containing only non-infected cardiac spheroids and two containing only T. cruzi-infected cardiac spheroids. One of the infected plates was treated with a single dose of 10 μM SB 431542 (4-[4-(1,3-benzodioxol-
(Tocris, BioTechne) for 96 h. Our experimental conditions were named as follows: non-infected cardiac spheroids (NI), infected cardiac spheroids (I) and infected and treated cardiac spheroids (IT).
Protein sample preparation
All spheroids from one plate were gathered in a plastic centrifuge tube, washed 3 times (PBS, pH 7.2) and resuspended in RIPA buffer (50 mM Tris-Cl pH 8.0, 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate) containing 1:100 protease and phosphatase inhibitor cocktails (Sigma-Aldrich). Spheroids were then disrupted by short pulses of sonication (XL-2000 Misonix Sonicator, Qsonica LLC). Protein concentration was determined by the RCDC method (BioRad), using bovine serum albumin (BSA) as standard. Samples were stored at −80°C until use.
Measurement of TGF-β levels by ELISA
Measurement of TGF-β levels in culture supernatants was performed using TGFβ1 Emax® ImmunoAssay System (Promega), according to the manufacturer's protocol. Measurement of total TGF-β (active + latent) was performed by heat activation (80°C) of latent TGF-β before the addition of samples into ELISA microplates.
Immunofluorescence and confocal microscopy of whole mount spheroids
Cardiac spheroids were fixed in 4% (v/v) paraformaldehyde and permeabilized with 0.5% (v/v) Triton X-100. After blockage with 3% (w/v) BSA, cardiac spheroids were incubated overnight at 4°C with primary mouse monoclonal antibodies specific for FN or LN (both from Sigma-Aldrich). Samples were incubated for 5 h at room temperature with a secondary antibody conjugated to Alexa Fluor 488 (Life). DNA was stained with DAPI. For further volume analysis, spheroids were counterstained with 0.01% (v/v) Evans Blue dye. After all steps, spheroids were suspended in DABCO anti-fading mounting medium and placed in confocal dishes (MatTek Corporation). Analyses were performed in a Zeiss LSM 510 Meta Laser Scanning Microscope (Carl Zeiss Microscopy).
Volume analysis
Volumes were evaluated using tools from ZEN lite software (Carl Zeiss Microscopy). The program allows the measurement of radius (r) from spheroids. The volume (V) of each spheroid was then calculated from the obtained radius and the use of the sphere volume equation (V = ⁴⁄₃πr³).
Evaluation of parasite load by quantitative real-time PCR (qPCR)
Total DNA (60 spheroids from each biological replicate) was extracted using the TRI-Reagent (Sigma-Aldrich, USA). The absolute quantification of T. cruzi DNA was performed in Applied Biosystems 7500 Fast Real-Time PCR instrument using TaqMan Universal Master  Mix  II  [2X] , DNA samples, primers Cruzi 1 (5'-ASTCGGCTGATCGTTTTCGA-3') and Cruzi 2 (5'-AATTCCTCCAAGCAG CGGATA-3') and probe Cruzi 3 (5'-FAM-CACACACTG GACACCAA-NFQ-MGB-3") targeting T. cruzi nuclear satellite DNA [18] [19] [20] . The absolute quantification of mice cardiac cell DNA was performed in a similar TaqMan assay targeting mice glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (# Mm99999915-g1, Life Technologies, USA). The standard curves were generated by serial dilutions of (1) T. cruzi DNA (from epimastigotes of Y strain), ranging from 10 6 to 10 0 parasite equivalents, and (2) cardiac cell DNA, ranging from 1.5 × 10 6 to 1. load per cardiac cell. The qPCR assays were performed in duplicate for each sample, and three biological replicates were analyzed.
Western blot
20 μg of protein were loaded and separated on 12% SDS-polyacrylamide gels (SDS-PAGE). After that, proteins were transferred to nitrocellulose membranes (Hybond C, GE). Uniform sample loading and transfer were verified using Memcode reversible protein stain (Pierce). GAPDH was also used as a loading control in Western blot experiments. Non-specific binding sites were blocked with 5% (w/v) nonfat milk/ TBS/Tween-20 0.1% overnight at 4°C. The membranes were probed overnight with specific primary antibodies (anti-FN and anti-LN, both from Sigma-Aldrich; anti-pSMAD2, from Cell Signaling; anti-TIMP-1, from R&D and anti-GAPDH, from Ambion) diluted in block solution. Membranes were probed for 1 h at room temperature with a peroxidase-conjugated secondary antibody (Pierce). Blots were developed using Supersignal West Pico Chemiluminescent Substrate (Pierce), recorded on autoradiography film and scanned in a GS-800 scanner (BioRad).
Gel zymography
40 μg of protein were loaded and separated on 12% SDS-PAGE with 0.1% gelatin incorporated as substrate. After running, gels were soaked in a sequence of baths (15 min in 2.5% Triton X-100 followed by 15 min in 2.5% Triton X-100 / 50 mM Tris-Cl pH 7.5 and 10 min, twice, in 50 mM Tris-Cl pH 7.5), under constant shaking. Gels were incubated overnight at 37°C in a 50 mM Tris-Cl pH 7.5 / 10 mM CaCl 2 solution and then stained with 0.5% Coomassie brilliant blue R-250 and scanned in a GS-800 scanner (BioRad). The molecular masses of MMPs were estimated in Quantity One software (BioRad) by comparison with standards of PageRuler Plus Prestained Protein Ladder (Thermo Scientific). To confirm that bands were related to the activity of MMPs, gels were incubated with 10 mM of 1, 10-phenanthroline in the overnight buffer. This compound inhibits zinc-dependent MMPs by chelation of the metal ion required for catalytic activity. After staining with Coomassie blue, any band could be detected in gels.
Statistical analysis
Statistical analyses were performed in IBM SPSS Statistics, version 20.0 (IBM Corporation, Armonk, NY, USA) using Mann-Whitney U test and Median test. For each experiment, three or more independent biological replicates were analyzed. Values were considered statistically significant when P < 0.05.
